Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretransplantation Red Blood Cell and Platelet Transfusion Burden in De Novo Myelodysplastic Syndrome Undergoing Allogeneic Transplantation.
Konuma T, Aoki J, Ozawa Y, Uchida N, Kobayashi T, Onizuka M, Katayama Y, Ohta T, Nakano N, Ota S, Onishi Y, Kobayashi H, Fukuda T, Kanda Y, Atsuta Y; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation. Konuma T, et al. Among authors: kanda y. Transplant Cell Ther. 2021 Aug;27(8):671-678. doi: 10.1016/j.jtct.2021.05.003. Epub 2021 May 12. Transplant Cell Ther. 2021. PMID: 33991723 Free article.
Limited efficacy of lamivudine against hepatitis B virus infection in allogeneic hematopoietic stem cell transplant recipients.
Ohnishi M, Kanda Y, Takeuchi T, Won Kim S, Hori A, Niiya H, Chizuka A, Nakai K, Saito T, Makimoto A, Tanosaki R, Watanabe T, Kobayashi Y, Tobinai K, Takaue Y, Mineishi S. Ohnishi M, et al. Among authors: kanda y. Transplantation. 2002 Mar 15;73(5):812-5. doi: 10.1097/00007890-200203150-00027. Transplantation. 2002. PMID: 11907433
Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
Saito T, Kanda Y, Kami M, Kato K, Shoji N, Kanai S, Ohnishi T, Kawano Y, Nakai K, Ogasawara T, Matsubara H, Makimoto A, Tanosaki R, Tobinai K, Wakasugi H, Takaue Y, Mineishi S. Saito T, et al. Among authors: kanda y. Clin Cancer Res. 2002 Apr;8(4):1014-20. Clin Cancer Res. 2002. PMID: 11948108 Clinical Trial.
Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor.
Kanda Y, Tanosaki R, Nakai K, Saito T, Ohnishi M, Niiya H, Chizuka A, Yakushijin K, Urahama N, Ueda K, Iijima K, Ando T, Matsubara H, Kami M, Makimoto A, Kobayashi Y, Tobinai K, Mineishi S, Takaue Y. Kanda Y, et al. Br J Haematol. 2002 Jul;118(1):128-31. doi: 10.1046/j.1365-2141.2002.03693.x. Br J Haematol. 2002. PMID: 12100136 Free article.
Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000).
Kanda Y, Chiba S, Hirai H, Sakamaki H, Iseki T, Kodera Y, Karasuno T, Okamoto S, Hirabayashi N, Iwato K, Maruta A, Fujimori Y, Furukawa T, Mineishi S, Matsuo K, Hamajima N, Imamura M. Kanda Y, et al. Blood. 2003 Aug 15;102(4):1541-7. doi: 10.1182/blood-2003-02-0430. Epub 2003 Apr 24. Blood. 2003. PMID: 12714500 Free article.
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.
Hori A, Kanda Y, Goyama S, Onishi Y, Komeno Y, Mitani K, Kishi Y, Ogawa S, Imataki O, Chiba S, Kojima R, Hamaki T, Sakiyama M, Kami M, Makimoto A, Tanosaki R, Takaue Y, Hirai H; Japan Hematology and Oncology Clinical Study Group. Hori A, et al. Among authors: kanda y. Transplantation. 2005 Feb 15;79(3):372-4. doi: 10.1097/01.tp.0000151001.64189.1d. Transplantation. 2005. PMID: 15699774 Clinical Trial.
1,389 results